BioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure

Bulletin Express

Mar 01

BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.

Following this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.

The announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1136110878"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136110878\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136110878?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-01 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136110878","market":"hk","top_or_hot":-1,"title":"BioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure","media":"Bulletin Express","content":"<p>BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.</p>\n<p>Following this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.</p>\n<p>The announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-01 18:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.</p>\n<p>Following this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.</p>\n<p>The announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01875","symbol_name":"东曜药业-B","start_time":0,"source_url":"","article_id":"1136110878","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136110878","pubTimestamp":1772360817,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01875":"东曜药业-B"},"translate_title":"BioDlink International(1875)宣布更新相关证券及收购守则披露","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01875":1},"content_text":"BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.\nFollowing this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.\nThe announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}